Credit Suisse’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-18,435
| Closed | -$1.25M | – | 4454 |
|
|
2019
Q3 | $1.25M | Sell |
18,435
-57,638
| -76% | -$3.96M | ﹤0.01% | 2846 |
|
|
2019
Q2 | $4.42M | Sell |
76,073
-42,978
| -36% | -$2.55M | ﹤0.01% | 1838 |
|
|
2019
Q1 | $8.34M | Buy |
119,051
+17,865
| +18% | +$1.32M | 0.01% | 1352 |
|
|
2018
Q4 | $6.52M | Buy |
101,186
+73,367
| +264% | +$5.14M | 0.01% | 1410 |
|
|
2018
Q3 | $1.95M | Sell |
27,819
-1,153
| -4% | -$67.4K | ﹤0.01% | 2374 |
|
|
2018
Q2 | $1.46M | Sell |
28,972
-2,448
| -8% | -$97.1K | ﹤0.01% | 2723 |
|
|
2018
Q1 | $983K | Buy |
31,420
+2,873
| +10% | +$95.3K | ﹤0.01% | 2966 |
|
|
2017
Q4 | $977K | Sell |
28,547
-3,220
| -10% | -$103K | ﹤0.01% | 3013 |
|
|
2017
Q3 | $1.02M | Buy |
31,767
+11,993
| +61% | +$378K | ﹤0.01% | 3079 |
|
|
2017
Q2 | $643K | Sell |
19,774
-42,990
| -68% | -$1.36M | ﹤0.01% | 2974 |
|
|
2017
Q1 | $1.98M | Buy |
62,764
+4,567
| +8% | +$135K | ﹤0.01% | 2362 |
|
|
2016
Q4 | $1.71M | Buy |
58,197
+9,345
| +19% | +$285K | ﹤0.01% | 2559 |
|
|
2016
Q3 | $1.41M | Buy |
48,852
+18,639
| +62% | +$519K | ﹤0.01% | 2654 |
|
|
2016
Q2 | $783K | Sell |
30,213
-1,060
| -3% | -$28.2K | ﹤0.01% | 3129 |
|
|
2016
Q1 | $775K | Buy |
31,273
+17,702
| +130% | +$486K | ﹤0.01% | 2919 |
|
|
2015
Q4 | $478K | Sell |
13,571
-4,707
| -26% | -$126K | ﹤0.01% | 3418 |
|
|
2015
Q3 | $387K | Sell |
18,278
-57,371
| -76% | -$1.48M | ﹤0.01% | 3578 |
|
|
2015
Q2 | $2.1M | Buy |
75,649
+38,639
| +104% | +$1.09M | ﹤0.01% | 2511 |
|
|
2015
Q1 | $1.13M | Buy |
37,010
+9,354
| +34% | +$297K | ﹤0.01% | 2869 |
|
|
2014
Q4 | $884K | Buy |
27,656
+6,315
| +30% | +$206K | ﹤0.01% | 3245 |
|
|
2014
Q3 | $604K | Sell |
21,341
-57,668
| -73% | -$1.61M | ﹤0.01% | 3498 |
|
|
2014
Q2 | $2.16M | Sell |
79,009
-4,844
| -6% | -$129K | ﹤0.01% | 2646 |
|
|
2014
Q1 | $2.21M | Sell |
83,853
-67,880
| -45% | -$1.95M | ﹤0.01% | 2438 |
|
|
2013
Q4 | $4.44M | Buy |
151,733
+102,327
| +207% | +$3.25M | ﹤0.01% | 1946 |
|
|
2013
Q3 | $1.51M | Sell |
49,406
-28,684
| -37% | -$959K | ﹤0.01% | 2633 |
|
|
2013
Q2 | $2.48M | Buy |
+78,090
| New | +$2.56M | ﹤0.01% | 2109 |
|
Credit Suisse's GHDX Position: Q4 2019 in Review
Credit Suisse sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 18,435 shares — an estimated $1.25M sold.
Credit Suisse first reported a position in GHDX in Q2 2013 and held it in 26 quarters. The position peaked at $8.34M in Q1 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- Credit Suisse reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- Credit Suisse sold 18,435 Genomic Health, Inc. shares in Q4 2019, an estimated $1.25M.
- Credit Suisse first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 26 quarters.
- Credit Suisse's Genomic Health, Inc. position peaked at $8.34M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on Credit Suisse's 13F filing for Q4 2019, filed 12 Feb 2020.